Breast Cancer Trial, Recruiting NCT05654246 Sponsor: Susan G. Komen Breast Cancer Foundation Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05654246
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old (note: in Alabama and Nebraska the minimum age is 19, and in Mississippi and Pennsylvania the minimum age is 21).
  • People who have been diagnosed with cancer that started, or is suspected to have started, in the breast.
  • People who are currently living in the United States or one of its territories.
  • People who are able to read and understand English.

Who may not be able to join:

  • People under the age of 18 (or under 19 in Alabama and Nebraska, or under 21 in Mississippi and Pennsylvania).
  • People who do not have a diagnosis of breast cancer.
  • People who are not currently living in the United States or one of its territories.
  • People who are unable to read and understand English.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jerome Jourquin, Ph.D., M.S., Susan G. Komen

Phone: 1-877-465-6636

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Susan G. Komen Breast Cancer Foundation
Registry
ClinicalTrials.gov
Start date
17 November 2022
Est. completion
1 November 2032

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Engage participants representative of the United States breast cancer patient population in ShareForCures.; Integrate participant data into ShareForCures.; Facilitate scientific research using ShareForCures data.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov